» Articles » PMID: 35401562

Cell-Crossing Functional Network Driven by MicroRNA-125a Regulates Endothelial Permeability and Monocyte Trafficking in Acute Inflammation

Overview
Journal Front Immunol
Date 2022 Apr 11
PMID 35401562
Authors
Affiliations
Soon will be listed here.
Abstract

Opening of the endothelial barrier and targeted infiltration of leukocytes into the affected tissue are hallmarks of the inflammatory response. The molecular mechanisms regulating these processes are still widely elusive. In this study, we elucidate a novel regulatory network, in which miR-125a acts as a central hub that regulates and synchronizes both endothelial barrier permeability and monocyte migration. We found that inflammatory stimulation of endothelial cells induces miR-125a expression, which consecutively inhibits a regulatory network consisting of the two adhesion molecules VE-Cadherin (CDH5) and Claudin-5 (CLDN5), two regulatory tyrosine phosphatases (PTPN1, PPP1CA) and the transcription factor ETS1 eventually leading to the opening of the endothelial barrier. Moreover, under the influence of miR-125a, endothelial expression of the chemokine CCL2, the most predominant ligand for the monocytic chemokine receptor CCR2, was strongly enhanced. In monocytes, on the other hand, we detected markedly repressed expression levels of miR-125a upon inflammatory stimulation. This induced a forced expression of its direct target gene CCR2, entailing a strongly enhanced monocyte chemotaxis. Collectively, cell-type-specific differential expression of miR-125a forms a synergistic functional network controlling monocyte trafficking across the endothelial barrier towards the site of inflammation. In addition to the known mechanism of miRNAs being shuttled between cells extracellular vesicles, our study uncovers a novel dimension of miRNA function: One miRNA, although disparately regulated in the cells involved, directs a biologic process in a synergistic and mutually reinforcing manner. These findings provide important new insights into the regulation of the inflammatory cascade and may be of great use for future clinical applications.

Citing Articles

A novel OSA-related model of intermittent hypoxia in endothelial cells under flow reveals pronounced inflammatory pathway activation.

Muller M, Stihl C, Schmid A, Hirschberger S, Mitsigiorgi R, Holzer M Front Physiol. 2023; 14:1108966.

PMID: 37123277 PMC: 10133699. DOI: 10.3389/fphys.2023.1108966.


A Functional Network Driven by MicroRNA-125a Regulates Monocyte Trafficking in Acute Inflammation.

Tomasi S, Li L, Hinske L, Tomasi R, Amini M, Strauss G Int J Mol Sci. 2022; 23(18).

PMID: 36142632 PMC: 9503790. DOI: 10.3390/ijms231810684.


Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.

Yang S, Alalaiwe A, Lin Z, Lin Y, Aljuffali I, Fang J Biomolecules. 2022; 12(8).

PMID: 36008966 PMC: 9405611. DOI: 10.3390/biom12081072.


Potential Predictive Value of miR-125b-5p, miR-155-5p and Their Target Genes in the Course of COVID-19.

Li X, Wang Y, Zhou Q, Pan J, Xu J Infect Drug Resist. 2022; 15:4079-4091.

PMID: 35937783 PMC: 9346419. DOI: 10.2147/IDR.S372420.

References
1.
Yang B, Huang X, Xu S, Li L, Wu W, Dai Y . Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2. Front Immunol. 2021; 12:756825. PMC: 8552026. DOI: 10.3389/fimmu.2021.756825. View

2.
Hotchkiss R, Monneret G, Payen D . Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13(12):862-74. PMC: 4077177. DOI: 10.1038/nri3552. View

3.
Chatterjee V, Beard Jr R, Reynolds J, Haines R, Guo M, Rubin M . MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. PLoS One. 2014; 9(10):e110286. PMC: 4198252. DOI: 10.1371/journal.pone.0110286. View

4.
Fullerton J, Gilroy D . Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016; 15(8):551-67. DOI: 10.1038/nrd.2016.39. View

5.
Wade S, Ohnesorge N, McLoughlin H, Biniecka M, Carter S, Trenkman M . Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis. EBioMedicine. 2019; 47:402-413. PMC: 6796559. DOI: 10.1016/j.ebiom.2019.08.043. View